We recently posted that Covance’s revenues for their fourth quarter was up, despite the downturn economy. Today I came across this article on ClinicalTrialsToday that discusses how another clinical trials company, Phase Forward, has also reported strong earnings this past quarter. Their revenues for the 4th quarter were $48.3 million compared to $37.8 in Q4 the previous year.
Will we continue to see this trend in clinical trials companies when they report their 4th quarter earnings?
Friday, February 6, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment